These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 8846827)
1. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells. Garcia-Barrado MJ; Jonas JC; Gilon P; Henquin JC Eur J Pharmacol; 1996 Mar; 298(3):279-86. PubMed ID: 8846827 [TBL] [Abstract][Full Text] [Related]
2. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C. Tian YA; Johnson G; Ashcroft SJ Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541 [TBL] [Abstract][Full Text] [Related]
3. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells. Sato Y; Anello M; Henquin JC Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978 [TBL] [Abstract][Full Text] [Related]
4. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content. Anello M; Gilon P; Henquin JC Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920 [TBL] [Abstract][Full Text] [Related]
5. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells. Mariot P; Gilon P; Nenquin M; Henquin JC Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741 [TBL] [Abstract][Full Text] [Related]
6. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398 [TBL] [Abstract][Full Text] [Related]
7. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells. Lee K; Ozanne SE; Hales CN; Ashford ML Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Garrino MG; Schmeer W; Nenquin M; Meissner HP; Henquin JC Diabetologia; 1985 Sep; 28(9):697-703. PubMed ID: 3934021 [TBL] [Abstract][Full Text] [Related]
9. Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic beta-cells following stimulation by hypoglycemic sulfonylureas. Abrahamsson H; Berggren PO; Rorsman P FEBS Lett; 1985 Oct; 190(1):21-4. PubMed ID: 2412893 [TBL] [Abstract][Full Text] [Related]
10. Interplay between cytoplasmic Ca2+ and the ATP/ADP ratio: a feedback control mechanism in mouse pancreatic islets. Detimary P; Gilon P; Henquin JC Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):269-74. PubMed ID: 9657965 [TBL] [Abstract][Full Text] [Related]
11. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. Ball AJ; Flatt PR; McClenaghan NH Eur J Pharmacol; 2000 Nov; 408(3):327-33. PubMed ID: 11090651 [TBL] [Abstract][Full Text] [Related]
12. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition. Fujitani S; Okazaki K; Yada T Br J Pharmacol; 1997 Apr; 120(7):1191-8. PubMed ID: 9105692 [TBL] [Abstract][Full Text] [Related]
13. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685 [TBL] [Abstract][Full Text] [Related]
14. Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Henquin JC Diabetologia; 1980; 18(2):151-60. PubMed ID: 6988275 [TBL] [Abstract][Full Text] [Related]
15. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms. Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release. Gomis R; Mathias PC; Lebrun P; Malaisse-Lagae F; Sener A; Malaisse WJ Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221 [TBL] [Abstract][Full Text] [Related]
17. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels. Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830 [TBL] [Abstract][Full Text] [Related]
18. Effects of caffeine on cytoplasmic free Ca2+ concentration in pancreatic beta-cells are mediated by interaction with ATP-sensitive K+ channels and L-type voltage-gated Ca2+ channels but not the ryanodine receptor. Islam MS; Larsson O; Nilsson T; Berggren PO Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):679-86. PubMed ID: 7702559 [TBL] [Abstract][Full Text] [Related]
19. Metabolic, cationic and secretory response to D-glucose in depolarized and Ca(2+)-deprived rat islets exposed to diazoxide. Lebrun P; Antoine MH; Nguyen QA; Picton S; Malaisse WJ Cell Calcium; 2000 Apr; 27(4):213-22. PubMed ID: 10858667 [TBL] [Abstract][Full Text] [Related]
20. Insulin release from pancreatic islets of fetal rats mediated by leucine b-BCH, tolbutamide, glibenclamide, arginine, potassium chloride, and theophylline does not require stimulation of Ca2+ net uptake. Ammon HP; Glocker C; Waldner RG; Wahl MA Cell Calcium; 1989; 10(6):441-50. PubMed ID: 2505929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]